Related Experiment Video
Updated: Jul 12, 2025

07:32
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.4K
Correlation between Spectral CT Parameters and Ki67 Expression in Hepatocellular Carcinoma
Long Xu1, Feng Yu Sun1, Gui Xian Li1
1Department of Radiology, Ziyang People's Hospital, No. 576, Checheng Avenue, Ziyang, Sichuan, People’s Republic of China
Current Medical Imaging
|October 26, 2023
Summary
Spectral CT quantitative parameters correlate with Ki67 expression in hepatocellular carcinoma (HCC). This imaging technique may help predict tumor aggressiveness before surgery.
Area of Science:
- Radiology
- Oncology
- Medical Imaging
Background:
- Hepatocellular carcinoma (HCC) is a significant global health concern.
- Ki67 expression is a key biomarker for tumor proliferation and aggressiveness.
- Accurate preoperative assessment of Ki67 is crucial for treatment planning in HCC.
Purpose of the Study:
- To investigate the relationship between spectral computed tomography (CT) quantitative parameters and Ki67 expression in HCC.
- To determine if spectral CT can non-invasively predict Ki67 levels in HCC tumors.
Main Methods:
- Prospective study of 19 HCC patients undergoing spectral CT.
- Quantitative parameters including iodine concentration (IC), relative iodine concentration (RIC), and spectral slope (λ) were measured.
- Patients were categorized into high-Ki67 (≥10%) and low-Ki67 (<10%) groups based on postoperative pathology.
Main Results:
- Higher IC, RIC, and λ values were observed in the high-Ki67 group compared to the low-Ki67 group (P < 0.05).
- Significant positive correlations were found between spectral CT parameters (IC, RIC, λ) and Ki67 expression in both arterial and venous phases.
- Arterial-phase RIC showed the highest correlation (0.82) with Ki67 expression.
Conclusions:
- Quantitative spectral CT parameters are significantly correlated with Ki67 expression in HCC.
- Spectral CT offers a potential non-invasive method for assessing tumor proliferation and guiding preoperative clinical decisions in HCC management.

